Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models
Authors:
- Karolina PytkaKPKarolina Pytka
- Magdalena Jastrzębska-WięsekMJMagdalena Jastrzębska-Więsek
- Agata SiwekASAgata Siwek
- Monika Głuch-LutwinMGMonika Głuch-Lutwin
- Barbara MordylBMBarbara Mordyl
- Anna RapaczARAnna Rapacz
- Adam GałuszkaAGAdam Gałuszka
- Marian BłachutaMBMarian Błachuta
- Anna WaszkielewiczAWAnna Waszkielewicz
Open Access
- 10 November 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (11) , e0142499
Abstract
The aim of this study was to further characterize pharmacological properties of two phenylpiperazine derivatives: 1-{2-[2-(2,6-dimethlphenoxy)ethoxy]ethyl}-4-(2-methoxyphenyl)piperazynine hydrochloride (HBK-14) and 2-[2-(2-chloro-6-methylphenoxy)ethoxy]ethyl-4-(2- methoxyphenyl)piperazynine dihydrochloride (HBK-15) in radioligand binding and functional in vitro assays as well as in vivo models. Antidepressant-like properties were investigated in the forced swim test (FST) in mice and rats. Anxiolytic-like activity was evaluated in the four-plate test in mice and elevated plus maze test (EPM) in rats. Imipramine and escitalopram were used as reference drugs in the FST, and diazepam was used as a standard anxiolytic drug in animal models of anxiety. Our results indicate that HBK-14 and HBK-15 possess high or moderate affinity for serotonergic 5-HT2, adrenergic α1, and dopaminergic D2 receptors as well as being full 5-HT1A and 5-HT7 receptor antagonists. We also present their potent antidepressant-like activity (HBK-14—FST mice: 2.5 and 5 mg/kg; FST rats: 5 mg/kg) and (HBK-15—FST mice: 1.25, 2.5 and 5 mg/kg; FST rats: 1.25 and 2.5 mg/kg). We show that HBK-14 (four-plate test: 2.5 and 5 mg/kg; EPM: 2.5 mg/kg) and HBK-15 (four-plate test: 2.5 and 5 mg/kg; EPM: 5 mg/kg) possess anxiolytic-like properties. Among the two, HBK-15 has stronger antidepressant-like properties, and HBK-14 displays greater anxiolytic-like activity. Lastly, we demonstrate the involvement of serotonergic system, particularly 5-HT1A receptor, in the antidepressant- and anxiolytic-like actions of investigated compounds.Keywords
This publication has 50 references indexed in Scilit:
- Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-αProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptorsBioorganic & Medicinal Chemistry Letters, 2012
- Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agentsBioorganic & Medicinal Chemistry Letters, 2012
- The 5-HT7 receptor and disorders of the nervous system: an overviewPsychopharmacology, 2009
- Vilazodone: A 5‐HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective DisordersCNS Neuroscience & Therapeutics, 2009
- Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorderInternational Journal of Neuropsychopharmacology, 2008
- Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicidesJournal of Psychiatric Research, 2008
- 5-HT7 Receptor Antagonists as a New Class of AntidepressantsDrug News & Perspectives, 2007
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973